InnovAge (INNV) & Its Competitors Critical Contrast

InnovAge (NASDAQ:INNVGet Free Report) is one of 29 public companies in the “Health services” industry, but how does it contrast to its peers? We will compare InnovAge to related businesses based on the strength of its institutional ownership, valuation, earnings, risk, profitability, dividends and analyst recommendations.

Earnings & Valuation

This table compares InnovAge and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
InnovAge $684.07 million -$6.52 million -21.90
InnovAge Competitors $429.10 million -$103.68 million 10.25

InnovAge has higher revenue and earnings than its peers. InnovAge is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for InnovAge and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InnovAge 0 0 0 0 N/A
InnovAge Competitors 7 119 228 0 2.62

InnovAge currently has a consensus target price of $8.00, indicating a potential upside of 17.82%. As a group, “Health services” companies have a potential upside of 66.23%. Given InnovAge’s peers higher possible upside, analysts clearly believe InnovAge has less favorable growth aspects than its peers.

Institutional and Insider Ownership

12.2% of InnovAge shares are held by institutional investors. Comparatively, 37.6% of shares of all “Health services” companies are held by institutional investors. 0.3% of InnovAge shares are held by company insiders. Comparatively, 23.9% of shares of all “Health services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

InnovAge has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, InnovAge’s peers have a beta of 1.44, suggesting that their average share price is 44% more volatile than the S&P 500.


This table compares InnovAge and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
InnovAge -6.17% -13.04% -7.48%
InnovAge Competitors -163.91% -245.82% -17.82%

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. As of June 30, 2022, it served approximately 6,650 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with's FREE daily email newsletter.